Live Breaking News & Updates on Neck Cancer Patient

Stay updated with breaking news from Neck cancer patient. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

AVEO Oncology Enrolls First Patient in Pivotal FIERCE-HN Clinical Trial to Evaluate Ficlatuzumab in Combination with ERBITUX® (cetuximab) in Patients with HPV-negative Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC)

Phase 3 Registrational Trial Seeks to Improve Survival Outcomes in Underserved HPV-negative R/M Head and Neck Cancer Patient PopulationTrial Launch Follows FDA Fast Track Designation of. ....

United States , Eli Lilly , Michael Bailey , Johnf Kouten , Juliee Bauman , George Washington Cancer Center , Drug Administration , Lg Chem Ltd , Lg Chem Life Sciences , Lg Chem Life Sciences Innovation Center Inc , George Washington School Of Medicine Health Sciences , Pharmaceuticals Inc , Communications Inc , Trial Seeks , Improve Survival Outcomes , Neck Cancer Patient , Track Designation , Fast Track , George Washington School , Life Sciences Innovation Center , Life Sciences ,